EU money intended for underfunded public-benefit research such as preparing for a pandemic has been diverted by the pharmaceutical industry into areas where it can make more money, according to a scathing new report.
Officials in Brussels wanted to co-fund research that would have ensured the European Union (EU) was better prepared for a pandemic akin to the one we are experiencing today. But their partners, the big pharmaceutical companies, rejected the proposal, ensuring that taxpayer money would go instead into studies with more potential for commercial application. In short big-pharma lobbyists were allowed to steer billions of euros of public funds as they saw fit, a damning new report claims.
Continue reading https://on.rt.com/ahtw